Miyamoto, S., Arashiro, T., Adachi, Y., Moriyama, S., Kinoshita, H., Kanno, T., . . . Suzuki, T. (2022). Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants. Med (New York, N.Y. : Online), 3(4), 249-261.e4. https://doi.org/10.1016/j.medj.2022.02.006
Chicago Style (17th ed.) CitationMiyamoto, Sho, et al. "Vaccination-infection Interval Determines Cross-neutralization Potency to SARS-CoV-2 Omicron After Breakthrough Infection by Other Variants." Med (New York, N.Y. : Online) 3, no. 4 (2022): 249-261.e4. https://doi.org/10.1016/j.medj.2022.02.006.
MLA (9th ed.) CitationMiyamoto, Sho, et al. "Vaccination-infection Interval Determines Cross-neutralization Potency to SARS-CoV-2 Omicron After Breakthrough Infection by Other Variants." Med (New York, N.Y. : Online), vol. 3, no. 4, 2022, pp. 249-261.e4, https://doi.org/10.1016/j.medj.2022.02.006.